RP-HPLC Method for Simultaneous Determination of Sofosbuvir and Ledipasvir in Tablet Dosage Form and Its Application to In Vitro Dissolution Studies

Validation and Application of a Liquid Chromatography-Tandem Mass Spectrometry Method To Determine the Concentrations of Sofosbuvir Anabolites in Cells

(2015) Joseph E. Rower et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS

(2015) Xiaojun Shi et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study

(2015) Mamdouh R. Rezk et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Sofosbuvir

(2014) Lucia Rose et al.   ANNALS OF PHARMACOTHERAPY

Sofosbuvir: First Global Approval

(2014) Gillian M. Keating et al.   DRUGS

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

(2013) John O. Link et al.   JOURNAL OF MEDICINAL CHEMISTRY

Integrating Phylodynamics and Epidemiology to Estimate Transmission Diversity in Viral Epidemics

(2013) Gkikas Magiorkinis et al.   PLoS Computational Biology

Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More

(2011) B. L. Pearlman et al.   CLINICAL INFECTIOUS DISEASES

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

(2011) Marc G. Ghany et al.   HEPATOLOGY

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Perspectives on fibrosis progression in hepatitis C: an á la carte approach to risk factors and staging of fibrosis

(2010) Thierry Poynard et al.   ANTIVIRAL THERAPY

Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection

(2010) Ira M. Jacobson et al.   Clinical Gastroenterology and Hepatology

Evolving epidemiology of hepatitis C virus

(2010) D. Lavanchy   CLINICAL MICROBIOLOGY AND INFECTION

Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors

(2010) S. Naggie et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY